Genus sells vet pharmaceutical business for £14m

Animals genetics company Genus has sold Animalcare, its non-core veterinary pharmaceutical business, to animal health firm Ritchey for £14m.

The proceeds of the sale, which is subject to financing from Ritchey’s admission to the AIM market, will be used to reduce debt.

The sale is expected to be completed by 10 January.